| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| FEMASYS INC | Chief Reg & Clinical Officer | Stock Option (Right to Buy) | 23,600 | 28 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FEMY | FEMASYS INC | 28 Jan 2025 | 3 | $0 | 4 | Chief Reg & Clinical Officer | 30 Jan 2025, 19:33 |
| FEMY | FEMASYS INC | 01 Feb 2024 | 1 | $0 | 4 | SVP, Regulatory & Clinical | 02 Feb 2024, 16:42 |
| FEMY | FEMASYS INC | 10 Oct 2023 | 1 | $0 | 4 | SVP, Regulatory & Clinical | 01 Nov 2023, 21:40 |
| FEMY | FEMASYS INC | 10 Oct 2022 | 1 | $0 | 4 | SVP, Regulatory & Clinical | 17 Oct 2022, 16:48 |
| FEMY | FEMASYS INC | 10 Oct 2022 | 0 | $0 | 3 | SVP, Regulatory & Clinical | 17 Oct 2022, 16:19 |